Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Anemia, Refractory, with Excess of Blasts 24Myelodysplastic Syndromes 23Leukemia, Lymphocytic, Chronic, B-Cell 21Leukemia, Myelomonocytic, Chronic 20Hodgkin Disease 19Myeloproliferative Disorders 18Multiple Myeloma 16Lymphoma, Non-Hodgkin 16Leukemia 15Primary Myelofibrosis 14Lymphoma 14Congenital Abnormalities 14Anemia, Aplastic 14Lymphoma, Follicular 13Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Burkitt Lymphoma 11Lymphoma, B-Cell, Marginal Zone 10Neoplasms, Plasma Cell 9Myelodysplastic-Myeloproliferative Diseases 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Graft vs Host Disease 9Polycythemia Vera 8Blast Crisis 8

Interventions

fludarabine phosphate 7Cyclophosphamide 6Antilymphocyte Serum 6Busulfan 5fludarabine 4Melphalan 4Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2SRA737 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2AP 1903 reagent 2sargramostim 1prexasertib 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Spectrometry, Fluorescence 1Reverse Transcriptase Polymerase Chain Reaction 1Quercetin 1Polymerase Chain Reaction 1Optical Imaging 1Molecular Diagnostic Techniques 1Microarray Analysis 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fanconi Anemia × Tacrolimus × Classical hematology × Clear all
NCT00053989 2020-02-10

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Roswell Park Cancer Institute

Phase 2 Completed
41 enrolled 13 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Fanconi Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡